. . . . . . . . . . . . "[Recently, EGFR mutations have been evaluated in CRC and were shown to occur at a very low frequency (<0.5%), supporting that, mutations on the EGFR gene, cannot explain cetuximab efficacy in irinotecan-refractory patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2014-02-25"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2014-10-02T12:33:22+02:00"^^ . . . . . . . . . . . "v2.1.0.0" . "v2.1.0" .